There is evidence that the insulin-like growth factor-I (IGF-I) receptor is required for transformation by a variety of viral and cellular oncogenes in a mouse embryo fibroblast model. To further investigate the IGF-I receptor signaling pathways that are required for the permissive effect of the receptor on transformation by SV40 T antigen, we established three independent fibroblast cell lines each from wild-type and IGF-I receptor null embryos (R À ). We transfected the wildtype and R À cell lines with an SV40 T antigen plasmid and selected three clones from each cell line that expressed T antigen. As in previous reports, none of the cloned R À cell lines expressing T antigen were transformed as measured by the ability to form large colonies in soft agar. However, with further passage, all three T antigen-expressing clones from one of the R À cell lines (R À 3) formed large colonies in soft agar and the transformation of these T antigen-expressing clones was confirmed by tumorigenesis experiments in immunodeficient mice. DNA microarray analysis comparing gene expression between early passage and late passage R À 3/T antigen clones showed, among other changes, an increase in the expression of ErbB-3 mRNA in the late passage clones. Also, the expression of ErbB-3 protein was dramatically increased in the late passage R À 3/T antigen clones. We conclude that late passage IGF-I receptor null mouse embryo fibroblasts can be transformed by SV40 T antigen, and that ErbB-3 may play a role in permitting transformation by T antigen. (Cancer Res 2006; 66(8): 4233-9) 
Introduction
Over the past decade, evidence has accumulated that insulin-like growth factors (IGF-I and IGF-II) play an important role in cancer development and progression. High blood IGF-I levels are a risk factor for development of cancer of the breast, prostate, colon, and lung (1). Cell lines from a variety of human cancers have been shown to be responsive to IGFs in monolayer culture (2, 3) . The IGF-I receptor and IGF-II have been shown to be overexpressed in some cancers (4) . There is genetic evidence that the M6P/ IGF-II receptor, which provides a degradative pathway for IGF-II, is a tumor suppressor (5) . Importantly, interference with IGF-I receptor expression or function by monoclonal antibodies (6, 7) , antisense RNA (8) , small-molecule tyrosine kinase inhibitors (9) , or dominant-negative receptor expression (10) have been shown to block the growth of tumors in vivo.
There is also evidence that the IGF-I receptor is required for transformation by a variety of viral and cellular oncogenes or overexpressed growth factor receptors in a mouse embryo fibroblast (MEF) model. Thus, an MEF cell line from the Igf1r knockout mouse could not be transformed by SV40 T antigen (11) , Ha-ras (12) , activated c-src (13) , human papilloma virus E7 (14) , bovine papilloma virus E5 (15) , Ewing sarcoma fusion protein (16) , or overexpressed platelet-derived growth factor (PDGF) receptor (17) and epidermal growth factor (EGF) receptor (18) . The transformed phenotype was restored when IGF-I receptor null fibroblasts carrying the SV40 T antigen were stably transfected with a plasmid expressing the human IGF-I receptor (11) . These important results suggested that the IGF-I receptor has a broader role in cancer biology than was previously recognized.
When overexpressed in MEFs the IGF-I receptor causes transformation as measured by colony formation in soft agar and tumor formation in immunodeficient mice (19) . By overexpressing various mutant IGF-I receptors and assessing transformation, it was discovered that the carboxy tail of the IGF-I receptor was required for transformation but was not required for proliferation (20) (21) (22) . It is not known whether the receptor signaling pathways required for transformation in the receptor overexpression model correspond to the pathways required for the permissive role in transformation by various viral and cellular oncogenes. However, Surmacz et al. (20) reported that an IGF-I receptor with a 108-amino acid carboxy tail deletion, which was impaired for transforming activity, but not for mitogenesis, was also unable to permit transformation of Igf1r null cells by SV40 T antigen. This suggests that there may be some concordance in the IGF-I receptor carboxy tail signaling pathways that are required in the two models. Additional clues about the identity of IGF-I receptor signaling pathways that are required for transformation by SV40 T antigen come from the observations that overexpression of IRS-1 (23) or Grb2 (24) in R À /T antigen cells restored transformation. To further investigate the IGF-I receptor signaling pathways required for the permissive effect of the receptor on transformation by SV40 T antigen, we established cell lines from R À and wild-type (WT) mouse embryos. In agreement with a previous report (11) , clones of early passage T antigen transfectants from three R À cell lines did not exhibit a transformed phenotype. However, all three clones of T antigen transfectants from one of the R À cell lines became transformed by T antigen with further passage, and ErbB-3 mRNA and protein were increased in these clones.
University, New York, NY) to A. Dlugosz for mating (25) . Four normal-sized and four small embryos were selected from a litter. /60 mm dish and incubated at 37jC in an atmosphere of 5% CO 2 . After 3 days of growth, monolayers were trypsinized and subcultured at a density of 3 Â 10 5 /60 mm dish. This subculturing protocol (3T3) was repeated every 3 days until cell lines were established as assessed by increased proliferation rate or ability to proliferate after plating at low density. The WT and R À cell lines were not single cell cloned.
Genotyping. DNA was purified from MEF cell lines (Qiagen DNA Mini Kit) and PCR amplification was done using primers which flank exon 3 of the mouse Igf1r gene (primer 1, ATCATCCTTACCACCCTCT; primer 2, GGCACCCTCAAAGTTTAG). The WT allele generates a 536 bp product. The knockout allele containing the neo cassette generates a 1,336 bp product. PCR was also done with neo cassette primers (27) (28) . DNA synthesis. DNA synthesis in the MEF lines was measured using a bromodeoxyuridine (BrdUrd) immunocytochemical/histochemical assay (5-bromo-2V-deoxyuridine labeling and detection kit II, Roche Molecular Biochemicals, Mannheim, Germany). Cells were plated in growth medium in LABTEKII chamber slides (PGC Scientific, Frederick, MD) at a density of 500 cells per well, and 24 hours later, medium was changed to serum-free medium. After 48 hours, medium containing 2 ng/mL EGF (PeproTech, Rocky Hill, NJ), 0.5 ng/mL PDGF (PeproTech) and 0, 10, or 50 ng/mL of IGF-I (PeproTech) was added. After 19 to 24 hours (WT2, 19 hours; WT3, 21 hours; WT4, 21 hours; R ) from Upstate (Charlottesville, VA) and ErbB-3, Nck1, adenomatous polyposis coli (APC), and connective tissue growth factor (CTGF) from Santa Cruz (Santa Cruz, CA). Phosphorylated focal adhesion kinase (FAK) was also measured by first immunoprecipitating the extract with anti-FAK agarose beads and immunoblotting with anti phospho-Tyr after analysis by SDS-PAGE and transfer to nitrocellulose membrane. Blots were incubated with the appropriate horseradish peroxidase secondary antibody and detected using enhanced chemiluminescence.
Colony formation in soft agar. The soft agar assay for measuring transformation was done as previously described (29) , except that 3 Â 10 4 cells were plated in duplicate 35 mm dishes with a grid of 2 mm squares on the bottom of the dish. The lower agar layer was 0.51% agar and the upper layer containing the cells was 0.34% agar. DMEM with 10% FCS (200 AL) was added at weekly intervals. Colonies z100 Am in diameter were counted after 2 weeks. Colony size was measured with a 100-point 10 mm reticle mounted in the eyepiece of the microscope. Experiments were begun immediately after identification of T antigen-expressing clones and were repeated two to four times for each clone over the following month (early passage cells). After this month of cell culture, we noticed that the R À 3/T antigen clones began to exhibit anchorage-independent growth and experiments on these late passage cells were repeated over the following month. Statistical analysis of the comparison of T antigen and empty vector transfectants used Student's t test.
Tumorigenesis in nude mice. Weanling mice (nu/nu) were injected s.c. in the intrascapular region with 1 Â 10 7 cells. Clones of T antigen or empty vector transfectants were injected. Five mice were injected with each clone. Tumor width and length measurements were made every 3 to 4 days for 9 weeks. Tumor volume was calculated for a prolate ellipsoid and converted into milligrams assuming a specific gravity of 1.0 ( Gene expression was also compared in three clones of WT3/vector cells and three clones of WT3/T antigen cells in order to screen out genes which changed as a result of transformation by T antigen. RNA was prepared from cells growing in log phase using the RNeasy kit from Qiagen. Experimental sample RNAs were converted to Cy5-labeled cDNA and cohybridized on DNA microchips with RNA from a reference pool labeled with Cy3. The reference pool is a mixture of total RNA from 20 cell lines, representing many cell lineages, which serves as a common denominator against which all samples may be compared. After determining the signal intensity for each element by confocal laser microscopy using a Genepix scanner (Molecular Devices, Sunnyvale, CA), gene expression was expressed as the ratio of the experimental sample signal divided by the reference pool signal (Cy5/Cy3). Only those genes that met quality control confidence criteria and were verified were considered for subsequent analysis. Hierarchical clustering was done using the Cluster and Treeview programs (32) . Comparisons between the early and late R À 3/T antigen clones were expressed as fold differences and only genes for which fold differences were >1.5 were reported. Statistical analyses of the comparisons used Student's t test and P < 0.05 were considered significant.
Results
Establishment of WT and IGF-I receptor null fibroblast lines. Heterozygous IGF-I receptor knockout mice (25) were mated. At 16 days of gestation, some of the embryos were only 1/2 to 2/3 the size of other embryos in the litter. These small embryos were assumed to be Igfr(À/À), whereas the larger embryos were assumed to be either Igfr(+/+) or Igfr(+/À). To establish cell lines from WT and R À embryos, the 3T3 protocol of Todaro and Green (26) was adapted. Cells were trypsinized and counted every third day and 3 Â 10 5 cells were freshly plated on a 60 mm dish. The prototypic proliferation pattern during the process of establishment of MEF cell lines is that the proliferation rate over a 3-day period initially is high and then declines to 0 after approximately 10 passages (crisis; ref. 26) . Proliferation rate then gradually increases, and at this point, a cell line has been established. We were able to establish cell lines from three WT and three We transfected WT and R À cell lines with a pRSVneo vector containing the SV40 early region encoding large and small T antigens (34) . Transfectants were single cell cloned and then tested for T antigen expression by immunoblotting cell lysates after SDS-PAGE (data not shown). Three T antigen-transfected and three empty vector-transfected clones were chosen from each of the WT and R À cell lines. The number of large colonies (>100 Am) in soft agar after 2 weeks was used as a measure of transformation ( Fig. 2A and B) . The results of the soft agar assay were confirmed by a more stringent test of transformation, tumorigenesis in nude mice ( Fig. 2C and D) . The WT3 T antigen clones and the late passage R À 3 T antigen clones produced fibrosarcomas in nude mice, whereas the vector-only clones did not produce tumors (WT3) or produced tumors which appeared only after 65 days (R À 3).
Expression of IRS-1, Grb2, and phospho-FAK in early and late passage R Similarly, overexpression of Grb2 in R À /T antigen cells resulted in transformation as measured by colony formation in soft agar (24) . R À cells could be transformed by v-src but not by activated c-src (13) . The v-src transformed R À cells exhibited higher levels of tyrosine phosphorylation of FAK. These observations prompted us to examine the expression of IRS-1, Grb2, and phospho-FAK in early and late passage R À 3/T antigen cells (Fig. 3) . IRS-1 expression was not increased in the late passage cells. Increase in Grb2 was not a uniform finding among the three late passage clones. The level of phosphorylated FAK was examined by a combination of immunoprecipitation with anti-FAK beads and immunoblotting with anti-pTyr and found not to be increased in the late passage cells. In addition, the level of phosphorylation on specific tyrosine residues (Tyr 397 and Tyr 576 ) of FAK was not increased in the late passage cells. Tables 1 and 2 , we eliminated genes whose differences in expression were a result of (rather than a prelude to) T antigen transformation, as determined by comparison of gene expression in three clones of WT3/vector and three clones of WT3/T antigen cells (Fig. S1 and File 1 in Supplementary Data). Several of the genes that were expressed at higher levels in late passage R À 3/T antigen clones are important in cell cycle control or tumorigenesis: fibroblastactivating protein (Fap), Erbb3, Nck1, and frizzled (35-38). We were able to examine the expression of ErbB-3 protein and Nck1 protein in cells in log phase growth by immunoblotting of cell extracts. There was a dramatic increase in the expression of ErbB-3 in the late passage R À 3/T antigen clones (Fig. 4) . There was no difference in the expression of Nck1 between the early and late R À 3/T antigen clones (data not shown). In the list of genes that were expressed at lower levels in the late passage R À 3/T antigen cells, Apc and Ctgf have been shown to play roles in tumorigenesis, whereas lats2 is a putative tumor suppressor (39) (40) (41) (42) (43) . We were able to examine the expression of APC protein by immunoblotting and found no difference in the level of expression between early and late passage R À 3/T antigen cells in log phase growth (data not shown). CTGF was not detected in either the early or late passage R À 3/T antigen cells.
Discussion
In the current study, we have sought to further examine the findings of the Baserga laboratory (11) , that the IGF-I receptor must be present for transfection of MEFs by SV40 T antigen. We In many systems, it has been shown that extended passage of cultured cells could result in multiple genetic changes which increase susceptibility to transformation by cooperating oncogenes or which may even cause spontaneous transformation. For example, Kunisada et al. (47) reported that late passage rat embryo fibroblasts or cells taken from adult rats were more easily transformed by SV40 (49) reported that whereas early passage human mammary epithelial cells expressing human TERT (HMECshTERT) required expression of H-ras V12 for transformation by SV40 early region, late passage HMECs-hTERT could be transformed using SV40 early region alone. Here, we show that further passage of a IGF-I receptor null fibroblast line, has rendered the cells permissive for transformation by the SV40 early region. The role of the IGF-I receptor in spontaneous transformation of MEFs has not been studied. However, tumorigenesis experiments showed that the late passage R À 3/vector clone produced tumors in the immunodeficient mice if the experiment was carried out to 65 days, and this result suggests that the IGF-I receptor may not be required for spontaneous transformation. Other examples of IGF-I receptor-independent transformation are transformation by v-src (13) and transformation by a GTPase-deficient mutant of human G a13 (50) .
To identify the changes in late passage R À 3/T antigen cells that might permit transformation by T antigen, we analyzed gene expression by microarray analysis in early and late passage R À 3/T antigen clones. ErbB-3 gene expression was increased significantly in late passage R À 3/T antigen cells. Moreover, the expression of ErbB-3 protein was dramatically increased in the late passage cells. ErbB-3 is an impaired kinase due to substitutions in critical residues in its catalytic domain, and is only capable of signaling as a receptor heterodimer (36) . The favorite partner for ErbB-3 is ErbB-2, which lacks an activating ligand. The ErbB-3/ErbB-2 dimer is the most potent module of the ErbB receptor family for signaling proliferation and transformation. This is due in part to the presence of multiple phosphotyrosine residues in the carboxylterminus of ErbB-3, which are part of motifs that engage the p85 regulatory subunit of phosphoinositide-3-kinase, leading to activation of the Akt pathway. In addition, ErbB-2 enhances the affinity of the ErbB-3/ErbB-2 heterodimer for ligands and broadens the list of ligands that bind to the heterodimer. Also, down-regulation of the ErbB-2/ErbB-3 receptor pair by endocytosis is slower than for ErbB-1-containing pairs resulting in slower degradation of ligand and receptor. Although overexpression of ErbB-1 (EGF receptor) in R À /T antigen cells did not result in transformation (18) , it is possible that the ErbB-2/ErbB-3 heterodimer could activate other pathways that would permit transformation by T antigen. The microarray data in Supplemental Fig. S1 shows that the level of ErbB-3 in the early passage R À 3/T antigen clones is higher than the level in WT3/vector clones, suggesting that this relatively high basal level of ErbB-3 may be a distinguishing characteristic of the R À 3 cell line. Further increase in ErbB-3 levels in the late passage R À 3/T antigen clones may contribute to transformation by SV40 T antigen. We conclude that late passage IGF-I receptor null MEFs can be transformed by SV40 T antigen. Our finding of increased expression of ErbB-3 mRNA and protein in late passage R 
